InterShunt Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $23.4M

  • Investors
  • 8

InterShunt General Information

Description

Developer of a proprietary catheter system designed to provide relief to people suffering from heart failure. The company's system is an interatrial shunting device that requires no implant and no energy for the capturing and excision of tissue from the interatrial septum, enabling doctors to reduce left atrial pressure in heart failure patients.

Contact Information

Website
www.intershunt.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 42 Northern Stacks Drive
  • Suite 200
  • Fridley, MN 55421
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Vertical(s)
Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 42 Northern Stacks Drive
  • Suite 200
  • Fridley, MN 55421
  • United States

InterShunt Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InterShunt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 06-Sep-2024 $23.4M Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
3. Later Stage VC (Series AA) 10-Jun-2022 Completed Generating Revenue
2. Later Stage VC (Series A) 13-Dec-2021 $4.02M $4.02M Completed Generating Revenue
1. Accelerator/Incubator 27-Jul-2018 Completed Generating Revenue
To view InterShunt’s complete valuation and funding history, request access »

InterShunt Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-2
Series B-1
Series AA 115,495 $0.001000 $34.9 $34.9 1x $34.9 2.46%
Series A 230,508 $0.001000 $20.7 $20.7 1x $20.7 4.92%
To view InterShunt’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

InterShunt Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

InterShunt Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210153776-A1 Method and device for sizing an interatrial aperture Inactive 25-Nov-2019
EP-4054448-A1 Method and septostomy device for creating an interatrial aperture Pending 07-Nov-2019
EP-4054448-A4 Method and septostomy device for creating an interatrial aperture Pending 07-Nov-2019
WO-2021091566-A1 Method and septostomy device for creating an interatrial aperture Inactive 07-Nov-2019
EP-3154450-B1 Catheter for creating an interatrial aperture Active 13-Jun-2014 A61B17/3205
To view InterShunt’s complete patent history, request access »

InterShunt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InterShunt Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
IAG Capital Partners Venture Capital Minority
New Day Venture Capital Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
Accelerate Venture Partners Angel Group Minority
BioGenerator Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

InterShunt FAQs

  • When was InterShunt founded?

    InterShunt was founded in 2015.

  • Where is InterShunt headquartered?

    InterShunt is headquartered in Fridley, MN.

  • What is the size of InterShunt?

    InterShunt has 10 total employees.

  • What industry is InterShunt in?

    InterShunt’s primary industry is Therapeutic Devices.

  • Is InterShunt a private or public company?

    InterShunt is a Private company.

  • What is the current valuation of InterShunt?

    The current valuation of InterShunt is .

  • What is InterShunt’s current revenue?

    The current revenue for InterShunt is .

  • How much funding has InterShunt raised over time?

    InterShunt has raised $31.4M.

  • Who are InterShunt’s investors?

    IAG Capital Partners, New Day Venture Capital, MedTech Innovator, Accelerate Venture Partners, and BioGenerator Ventures are 5 of 8 investors who have invested in InterShunt.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process